Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06000423
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2023-08-14
Brief Title:
Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects
Sponsor:
Oregon Health and Science University
Organization:
Oregon Health and Science University
Study Overview
Official Title:
Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This randomized double blinded trial seeks to determine whether tranexamic acid TXA is an efficacious treatment for contraceptive induced menstrual changes CIMC including irregular bothersome bleeding caused by the etonogestrel subdermal contraceptive implant ENG implant Participants will be randomized into the TXA treatment arm or a placebo They will begin taking the medication after three consecutive days of bleeding Participants will track their bleeding using an automated text message service
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None